Pembrolizumab for recurrent/metastatic head and neck cancer: equally promising for Asian patients?

Affiliations

• ¹ Integrative Therapeutics Program, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.
• ² Medical Research Scholars Program, National Institutes of Health, Bethesda, MD, USA.
• ³ Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
• ⁴ Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University, Bethesda, MD, USA.